Skip to main content

Table 4 Time course of circulating level of EPCs

From: Effect of erythropoietin on level of circulating endothelial progenitor cells and outcome in patients after acute ischemic stroke

Variables

At 48 h

On Day 7

On Day 21

P- value*

Circulating EPCs in group 1

    

   CD31/CD34 (%)

1.65 ± 0.91a

1.52 ± 1.06a

2.28 ± 1.48b

<0.0001

   CD62E/CD34 (%)

1.21 ± 0.86a

1.11 ± 0.76a

1.50 ± 1.13b

0.0409

   KDR/CD34 (%)

1.34 ± 0.76a

1.16 ± 0.70a

1.81 ± 1.25b

0.0001

Circulating EPCs in group 2

    

   CD31/CD34 (%)

1.75 ± 1.03

1.48 ± 0.89

1.64 ± 0.79

0.071

   CD62E/CD34 (%)

1.16 ± 0.76

1.14 ± 0.75

1.14 ± 0.72

0.973

   KDR/CD34 (%)

1.37 ± 0.89

1.24 ± 0.80

1.22 ± 0.72

0.267

  1. *: by repeated measure of ANOVA.
  2. Letters (a, b) indicate significant difference (at 0.05 level) by Tukey multiple comparison procedure.